Cytotoxic anti-lag-3 monoclonal antibody and its use in the...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/00 (2006.01) C07K 16/28 (2006.01)

Patent

CA 2685584

The present invention concerns a molecule binding to LAG-3 protein and causing depletion of LAG-3' activated T cells particularly said molecule is a cytotoxic anti-LAG-3 monoclonal antibody or fragment thereof. It also concerns a method of treating or preventing organ transplant rejection or autoimmune diseases in a mammal comprising administering to said mammal a therapeutically effective amount of said antibody.

La présente invention porte sur une molécule se liant à la protéine LAG-3 et provoquant un épuisement de lymphocytes T activés par LAG-3'. En particulier, ladite molécule est un anticorps monoclonal anti-LAG-3 cytotoxique ou un fragment de celui-ci. L'invention porte également sur un procédé de traitement ou de prévention d'un rejet de greffon d'organe ou de maladies auto-immunes dans un mammifère, comprenant l'administration audit mammifère d'une quantité thérapeutiquement efficace dudit anticorps.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cytotoxic anti-lag-3 monoclonal antibody and its use in the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cytotoxic anti-lag-3 monoclonal antibody and its use in the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytotoxic anti-lag-3 monoclonal antibody and its use in the... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1444147

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.